Aurora Sheboygan Prices: Elotuzumab 300 Milligram Intravenous Solution at $156.36

Elotuzumab 300 Milligram Intravenous Solution is an advanced monoclonal antibody therapy used primarily for the treatment of multiple myeloma, a form of blood cancer affecting plasma cells in the bone marrow. At Aurora Medical Center Sheboygan County, the fee for a 300mg dose is $156.36. This price typically covers the medication itself and administration via intravenous infusion. Patients should note that additional costs—such as clinic fees, nursing, laboratory tests, and supportive medications—may not be included. To avoid unexpected expenses, it is advisable to request a detailed, itemized estimate from the facility and verify insurance coverage before treatment.

Cost Breakdown

• Elotuzumab (300mg, IV solution): $156.36 (medication and administration fee)
• Potential additional costs:
  • Infusion center/clinic facility fees
  • Nursing and monitoring charges
  • Pre-medication (e.g., steroids, antihistamines)
  • Laboratory and imaging tests
  • Follow-up consultations

Associated Costs and Considerations

• Insurance: Coverage for Elotuzumab varies by plan; prior authorization may be required. Out-of-pocket costs and co-pays can differ significantly.
• Financial Assistance: Manufacturer-sponsored programs and hospital financial services may help eligible patients with costs.
• Other Medications: Elotuzumab is often combined with other drugs (e.g., lenalidomide, dexamethasone), which may incur separate charges.

Recovery and Side-Effect Management Tips

• Plan for possible infusion-related reactions; ask about pre-medications to reduce risk.
• Arrange transportation if you feel fatigued after treatment.
• Monitor for side effects (e.g., fever, chills, allergic reactions) and promptly report concerns to your care team.
• Stay hydrated and get plenty of rest following infusions.

Frequently Asked Questions

• What is Elotuzumab used for?
  Elotuzumab is used to treat multiple myeloma, a cancer of plasma cells in the bone marrow.
• How is Elotuzumab administered?
  It is given as an intravenous infusion, meaning it is delivered directly into your bloodstream through an IV.
• What does the $156.36 fee include?
  This fee covers a single 300mg dose of Elotuzumab and its administration but may not include facility fees, labs, or other associated costs.
• Are there additional costs beyond the medication?
  Yes, you may be billed separately for infusion center use, nursing care, lab tests, and other medications given during treatment.
• Will my insurance cover Elotuzumab?
  Cancer therapies like Elotuzumab are often covered, but coverage and out-of-pocket costs depend on your individual insurance plan. Confirm details with your insurer and the treatment center.
• Can I get financial assistance for Elotuzumab?
  Many pharmaceutical companies and hospitals offer assistance programs for eligible patients to help reduce medication costs.
• How long does the infusion take?
  Infusion times vary but typically take several hours, especially for the first dose. Your care team will provide specifics based on your regimen.
• What side effects should I watch for?
  Common side effects include fatigue, fever, infusion reactions (such as chills or rash), and increased risk of infections. Notify your healthcare provider if you experience severe symptoms.
• Do I need to prepare for my infusion appointment?
  Follow any instructions from your care team, such as fasting or taking pre-medications. Arrange for a ride home if you feel unwell after treatment.
• Are there alternative treatments to Elotuzumab?
  Multiple myeloma is treated with a variety of therapies. Your oncologist can discuss alternative or complementary options based on your specific case.
• What should I do if I have billing questions?
  Contact the hospital’s billing department and request an itemized bill. Clarify any charges you do not understand and ask about financial assistance if needed.

Aurora Medical Center Sheboygan County offers a range of medical services, including specialized treatments such as Elotuzumab 300 Milligram Intravenous Solution. Elotuzumab is a monoclonal antibody used in the treatment of multiple myeloma, a type of blood cancer. At Aurora Sheboygan, the cost for this specific dosage of Elotuzumab is $156.36, reflecting the center’s commitment to providing essential cancer therapies at competitive prices. This pricing allows patients access to advanced medical treatments that can be crucial in managing their condition effectively.

What is Elotuzumab? – Elotuzumab is a monoclonal antibody used in the treatment of multiple myeloma, a cancer that affects plasma cells in the bone marrow.
How is Elotuzumab administered? – Elotuzumab is administered as an intravenous solution, meaning it is given directly into the bloodstream through an IV.
What is the cost of Elotuzumab at Aurora Medical Center Sheboygan County? – The cost for a 300 milligram intravenous solution of Elotuzumab at Aurora Medical Center Sheboygan County is $156.36.
Why is Elotuzumab used in cancer treatment? – Elotuzumab works by targeting specific proteins on the surface of cancer cells, helping the immune system to identify and destroy them, making it an effective treatment for multiple myeloma.
Are there any side effects associated with Elotuzumab? – Common side effects of Elotuzumab can include fatigue, fever, diarrhea, and respiratory infections, but patients should consult their healthcare provider for a comprehensive list.
Is Elotuzumab covered by insurance? – Coverage for Elotuzumab can vary depending on the patient’s insurance plan, so it is advisable to check with the insurance provider to understand the specifics of coverage.
How often is Elotuzumab administered? – The frequency of Elotuzumab administration depends on the treatment plan prescribed by the healthcare provider, typically involving multiple doses over a set period.
What should patients expect during an Elotuzumab infusion? – Patients can expect to be monitored closely during the infusion process to manage any potential reactions and ensure the treatment is administered safely.